Quarter of new drugs approved by FDA publicly funded
A study has found that 25 percent of drugs with one or more new molecular entities approved by the FDA come from publicly funded research.
List view / Grid view
News
FDA releases statement on reducing drug shortages
The FDA has announced its support of a drug manufacturer rating system that would allow purchasers to identify which have the most reliable supply, in an effort to reduce shortages.
NHS England and Vertex announce agreement for cystic fibrosis medicines
A new agreement will allow eligible cystic fibrosis patients in England to have access to CFTR modulators to treat the underlying cause of their disease.
New encapsulation technology could improve drug delivery
Encapsulation technology, a simple and efficient technique to coat liquid medication in milliseconds, could improve drug delivery.
FDA announces update to NDMA testing recommendations
The FDA has released an additional NDMA testing method and has alerted the public to multiple voluntary recalls of ranitidine.
Pelosi drug pricing bill approved by House committee
Speaker Pelosi’s bill to lower medicine prices in the US has passed through a House committee, ready for a full vote.
FDA approves drug to prevent heart failure in type 2 diabetes patients
Farxiga, a treatment to reduce the risk of heart failure in patients with type 2 diabetes has been approved by the FDA.
Precise cancer treatment possible with new nanotube drug delivery technology
A new drug delivery technology has been developed using nanotubes which can efficiently and precisely target lung cancer cells.
Sixty percent of search engine results for medicines yield counterfeit drugs
Research has found that up to 60 percent of results for medicines on search engines present potentially counterfeit pharmaceutical products.
Early Alzheimer’s disease treatment meets trial primary endpoints
Aducanumab, an Alzheimer's disease treatment, will be submitted as part of a Biologics License Application after meeting clinical trial primary endpoints.
FDA sends warning letter to company illegally selling CBD products
A business selling unapproved products containing CBD has been sent a warning letter from the FDA and FTC for making unsubstantiated claims about their therapeutic properties.
FDA approved 1,171 generic drugs in 2019
The FDA has released a statement on their generic drug approvals in FY 2019, revealing a new record high breaking above last year.
Breakthrough therapy for cystic fibrosis approved by FDA
Trikafta is the first approved treatment that is effective for patients 12 years and older with the most common cystic fibrosis mutation.
Teva to supply treatment in settlement agreement on Track 1 opioid case
Teva has agreed to supply opioid medication and make a cash payment in a settlement agreement that removes it from the Track 1 opioid litigation.
Global consortium formed to combat unproven cell banking services
The International Society for Cell and Gene Therapy has created a group to tackle the rising number of commercial cell bank services that are misleading patients.
